CDTX vs NVS
Cidara Therapeutics Inc (CDTX) versus NVS (NVS) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
NVS (NVS) common stock.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
NVS does not have a complete income-statement cache yet.
CDTX currently screens at market cap $6.96B. NVS currently screens at market cap $0.
Not investment advice. Open the CDTX and NVS stock pages for the full models.
Not investment advice.